Quadria-Backed Maxivision Appoints Bankers for India IPO

Maxivision, an India-based eye care chain backed by private equity firm Quadria Capital, has appointed investment bankers to initiate its initial public offering (IPO) process. According to Reuters, citing sources, the company aims to list on the Bombay Stock Exchange (BSE) to fund growth plans and provide an exit opportunity for existing investors. Sources indicated that Maxivision's IPO could be valued at approximately $150-200 million. The company is working with leading investment banks such as Kotak Mahindra Capital, JM Financial, and ICICI Securities for the process. Quadria Capital invested in Maxivision in 2018, helping the company expand to over 100 centers across more than 50 cities in India. India's eye care market is experiencing rapid growth due to an aging population and the increasing prevalence of eye diseases. Maxivision specializes in areas such as cataract and refractive surgery. The company's IPO could contribute to the recent trend of increasing IPOs in India's healthcare sector. While the selection of investment bankers and the timing of the IPO have not yet been finalized, the process is expected to be completed in the coming months. Maxivision's IPO would be the first exit from Quadria Capital's portfolio companies. This is not investment advice.